3/31
04:12 pm
bcab
BioAtla Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights [TheStreet.com]
Medium
Report
BioAtla Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights [TheStreet.com]
3/31
04:12 pm
bcab
BioAtla Announces Share Consolidation [TheStreet.com]
Medium
Report
BioAtla Announces Share Consolidation [TheStreet.com]
3/31
04:06 pm
bcab
BioAtla Announces Share Consolidation
Medium
Report
BioAtla Announces Share Consolidation
3/31
04:05 pm
bcab
BioAtla Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
High
Report
BioAtla Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
3/2
08:01 am
bcab
BioAtla Announces Formal Process to Evaluate Strategic Options to Monetize Assets [Yahoo! Finance]
High
Report
BioAtla Announces Formal Process to Evaluate Strategic Options to Monetize Assets [Yahoo! Finance]
3/2
07:30 am
bcab
BioAtla Announces Formal Process to Evaluate Strategic Options to Monetize Assets
High
Report
BioAtla Announces Formal Process to Evaluate Strategic Options to Monetize Assets
1/13
03:57 pm
bcab
BioAtla (NASDAQ:BCAB) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $4.00 price target on the stock.
Low
Report
BioAtla (NASDAQ:BCAB) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $4.00 price target on the stock.